−3.77USD
−436.37 MUSD
11.58 MUSD
136.49 M
About Revolution Medicines, Inc.
Sector
CEO
Mark A. Goldsmith
Headquarters
Redwood City
Website
Employees (FY)
378
Founded
2004
FIGI
BBG00829F4P8
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
RVMD - a biotech that ending consolidation?
Fundamentals: Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment. Average 1 year target from analysts = 54.
Technical: To allow the stock some fluctuation the stop
RVMDClassics of the genre. A young and beautiful company that has everything ready to make friends with you, that is, the Triangle pattern, which has already been formed and broken up. Now the price will move along the indicated arrows and reach the main target of the trade of 72.44 dollars (an increase
RVMD Revolution Medicines, Inc. - LONG$RVMD still very cheap imo...buy and hold, LT hold. Next MRTX ?
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where RVMD is featured.
Frequently Asked Questions
The current price of RVMD is 35.42 USD — it has decreased by 2.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Revolution Medicines, Inc. stocks are traded under the ticker RVMD.
Revolution Medicines, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
RVMD stock is 3.46% volatile and has beta coefficient of 1.58. Check out the list of the most volatile stocks — is Revolution Medicines, Inc. there?
RVMD earnings for the last quarter are −0.99 USD per share, whereas the estimation was −1.01 USD resulting in a 2.05% surprise. The estimated earnings for the next quarter are −0.85 USD per share. See more details about Revolution Medicines, Inc. earnings.
Yes, you can track Revolution Medicines, Inc. financials in yearly and quarterly reports right on TradingView.
RVMD stock has fallen by 2.93% compared to the previous week, the month change is a 14.29% rise, over the last year Revolution Medicines, Inc. has showed a 53.07% increase.
RVMD net income for the last quarter is −161.54 M USD, while the quarter before that showed −108.43 M USD of net income which accounts for −48.97% change. Track more Revolution Medicines, Inc. financial stats to get the full picture.
Today Revolution Medicines, Inc. has the market capitalization of 5.97 B, it has increased by 0.50% over the last week.
No, RVMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RVMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Revolution Medicines, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 378.00 employees. See our rating of the largest employees — is Revolution Medicines, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Revolution Medicines, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Revolution Medicines, Inc. stock shows the strong buy signal. See more of Revolution Medicines, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Revolution Medicines, Inc. future price: according to them, RVMD price has a max estimate of 48.00 USD and a min estimate of 34.00 USD. Read a more detailed Revolution Medicines, Inc. forecast: see what analysts think of Revolution Medicines, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Revolution Medicines, Inc. EBITDA is −477.88 M USD, and current EBITDA margin is −4.13 K%. See more stats in Revolution Medicines, Inc. financial statements.